DEMİRCİ, S. C. Et Al. 2024. Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism. Clinical Psychopharmacology and Neuroscience , vol.22, no.3 , 473-483.

DEMİRCİ, S. C., BARUN, S., ÖZASLAN, A., GÜLBAHAR, Ö., Bulut, T. S. D., Çamurdan, A. D., ... İŞERİ, E.(2024). Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism. Clinical Psychopharmacology and Neuroscience , vol.22, no.3, 473-483.

DEMİRCİ, SAMET Et Al. "Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism," Clinical Psychopharmacology and Neuroscience , vol.22, no.3, 473-483, 2024

DEMİRCİ, SAMET C. Et Al. "Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism." Clinical Psychopharmacology and Neuroscience , vol.22, no.3, pp.473-483, 2024

DEMİRCİ, S. C. Et Al. (2024) . "Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism." Clinical Psychopharmacology and Neuroscience , vol.22, no.3, pp.473-483.

@article{article, author={SAMET CAN DEMİRCİ Et Al. }, title={Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism}, journal={Clinical Psychopharmacology and Neuroscience}, year=2024, pages={473-483} }